UMP Healthcare Holdings 将来の成長

Future 基準チェック /06

現在、 UMP Healthcare Holdingsの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Healthcare 収益成長	19.1%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

Recent updates

UMP Healthcare Holdings (HKG:722) Is Paying Out Less In Dividends Than Last Year

Mar 02

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

Dec 01

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

Oct 26

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

Sep 24

UMP Healthcare Holdings (HKG:722) Will Pay A Larger Dividend Than Last Year At HK$0.017

Feb 26

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.03

Nov 16

UMP Healthcare Holdings (HKG:722) Will Pay A Larger Dividend Than Last Year At HK$0.03

Oct 26

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.03

Sep 26

Here's What To Make Of UMP Healthcare Holdings' (HKG:722) Decelerating Rates Of Return

May 13

UMP Healthcare Holdings (HKG:722) Is Paying Out A Larger Dividend Than Last Year

Feb 27

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.028

Nov 27

We Think UMP Healthcare Holdings Limited's (HKG:722) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 19

Investors Can Find Comfort In UMP Healthcare Holdings' (HKG:722) Earnings Quality

Oct 29

UMP Healthcare Holdings' (HKG:722) Dividend Will Be Increased To HK$0.028

Oct 12

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.028

Sep 25

UMP Healthcare Holdings (HKG:722) Might Be Having Difficulty Using Its Capital Effectively

Jul 27

A Look At The Fair Value Of UMP Healthcare Holdings Limited (HKG:722)

Apr 29

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、UMP Healthcare Holdings は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

SEHK:722 - アナリストの将来予測と過去の財務データ ( )HKD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2024	750	41	92	149	N/A
3/31/2024	744	37	86	166	N/A
12/31/2023	739	34	81	183	N/A
9/30/2023	733	47	81	187	N/A
6/30/2023	728	60	81	190	N/A
3/31/2023	700	64	N/A	N/A	N/A
12/31/2022	673	68	84	168	N/A
9/30/2022	670	70	55	139	N/A
6/30/2022	666	71	26	111	N/A
3/31/2022	671	72	N/A	N/A	N/A
12/31/2021	676	73	123	162	N/A
9/30/2021	647	74	135	167	N/A
6/30/2021	617	74	147	173	N/A
3/31/2021	584	66	93	121	N/A
12/31/2020	551	59	40	69	N/A
9/30/2020	555	59	68	98	N/A
6/30/2020	559	59	96	128	N/A
3/31/2020	587	67	103	132	N/A
12/31/2019	615	75	110	137	N/A
9/30/2019	593	44	71	92	N/A
6/30/2019	570	13	32	47	N/A
3/31/2019	540	8	N/A	N/A	N/A
12/31/2018	509	3	-27	35	N/A
9/30/2018	487	20	-62	31	N/A
6/30/2018	466	38	-98	26	N/A
3/31/2018	475	48	N/A	N/A	N/A
12/31/2017	485	59	N/A	34	N/A
9/30/2017	501	51	N/A	34	N/A
6/30/2017	516	44	N/A	35	N/A
3/31/2017	504	23	N/A	45	N/A
12/31/2016	491	2	N/A	54	N/A
9/30/2016	475	4	N/A	40	N/A
6/30/2016	458	7	N/A	25	N/A
3/31/2016	441	17	N/A	14	N/A
12/31/2015	424	28	N/A	2	N/A
9/30/2015	414	35	N/A	23	N/A
6/30/2015	403	41	N/A	44	N/A
6/30/2014	355	42	N/A	44	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 722の予測収益成長が貯蓄率 ( 2.3% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: 722の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: 722の収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: 722の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: 722の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 722の自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

成長企業の発掘

企業分析と財務データの現状

データ	最終更新日（UTC時間）
企業分析	2024/12/18 08:16
終値	2024/12/18 00:00
収益	2024/06/30
年間収益	2024/06/30

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージ	データ	タイムフレーム	米国ソース例
会社財務	10年	損益計算書キャッシュ・フロー計算書貸借対照表	SECフォーム10-K SECフォーム10-Q
アナリストのコンセンサス予想	+プラス3年	予想財務アナリストの目標株価	アナリストリサーチレポート Blue Matrix
市場価格	30年	株価配当、分割、措置	ICEマーケットデータ SECフォームS-1
所有権	10年	トップ株主インサイダー取引	SECフォーム4 SECフォーム13D
マネジメント	10年	リーダーシップ・チーム取締役会	SECフォーム10-K SECフォームDEF 14A
主な進展	10年	会社からのお知らせ	SECフォーム8-K

* 米国証券を例とし、非米国証券については同等の規制書式と情報源を使用^。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドや、Youtubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

UMP Healthcare Holdings Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、。アナリストの投稿は一日中更新されます。2

アナリスト	機関
Kam Wai Kwok	CGS International
Geng Chen	Phillip Securities (HK)

UMP Healthcare Holdings 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

UMP Healthcare Holdings Limited Provides Financial Guidance for Fiscal Year 2022

Recent updates

Upcoming dividend of HK$0.02 per share

UMP Healthcare Holdings Limited Approves A Final Dividend for the Year Ended 30 June 2024

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.02

There May Be Some Bright Spots In UMP Healthcare Holdings' (HKG:722) Earnings

Full year 2024 earnings released: EPS: HK$0.051 (vs HK$0.077 in FY 2023)

UMP Healthcare Holdings (HKG:722) Will Pay A Dividend Of HK$0.02

Independent Non-Executive Director recently bought HK$178k worth of stock

Independent Non-Executive Director recently bought HK$152k worth of stock

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.02

Final dividend reduced to HK$0.02

Full year 2024 earnings released: EPS: HK$0.051 (vs HK$0.077 in FY 2023)

UMP Healthcare Holdings Limited, Annual General Meeting, Nov 29, 2024

UMP Healthcare Holdings Limited Proposes Final Cash Dividend for the Year Ended 30 June 2024, Payable on 10 January 2025

UMP Healthcare Holdings Limited to Report Fiscal Year 2024 Results on Sep 25, 2024

Co-CEO & Executive Vice Chairman recently bought HK$83k worth of stock

Executive Chairman recently bought HK$58k worth of stock

First half 2024 earnings released: EPS: HK$0.02 (vs HK$0.054 in 1H 2023)

Upcoming dividend of HK$0.013 per share

Executive Chairman recently bought HK$60k worth of stock

UMP Healthcare Holdings (HKG:722) Is Paying Out Less In Dividends Than Last Year

First half dividend reduced to HK$0.013

UMP Healthcare Holdings Limited Announces Interim (Semi-Annual) Ordinary Dividend for the Six Months Ended 31 December 2023, Payable on 19 April 2024

UMP Healthcare Holdings Limited Announces Interim (Semi-Annual) Ordinary Dividend for the Six Months Ended 31 December 2023, Payable on 19 April 2024

UMP Healthcare Holdings Limited to Report First Half, 2024 Results on Feb 28, 2024

Co-CEO & Executive Vice Chairman recently bought HK$115k worth of stock

UMP Healthcare Holdings Limited Announces Change of Company Secretary and Authorised Representatives

Co-CEO & Executive Vice Chairman recently bought HK$81k worth of stock

Co-CEO & Executive Vice Chairman recently bought HK$104k worth of stock

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

Upcoming dividend of HK$0.03 per share at 7.2% yield

UMP Healthcare Holdings Limited Announces Board Changes

Executive Chairman recently bought HK$64k worth of stock

Executive Director recently bought HK$67k worth of stock

Full year 2023 earnings released: EPS: HK$0.077 (vs HK$0.092 in FY 2022)

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

UMP Healthcare Holdings Limited Proposes to Declare Final Dividend for the Year Ended 30 June 2023

Executive Chairman recently bought HK$139k worth of stock

Executive Chairman recently bought HK$70k worth of stock

UMP Healthcare Holdings (HKG:722) Is Due To Pay A Dividend Of HK$0.03

UMP Healthcare Holdings Limited, Annual General Meeting, Nov 24, 2023

Full year 2023 earnings released: EPS: HK$0.077 (vs HK$0.092 in FY 2022)

UMP Healthcare Holdings Limited to Report Fiscal Year 2023 Results on Sep 21, 2023

Independent Non-Executive Director recently bought HK$81k worth of stock

Upcoming dividend of HK$0.017 per share at 5.7% yield

Independent Non-Executive Director recently bought HK$79k worth of stock

UMP Healthcare Holdings (HKG:722) Will Pay A Larger Dividend Than Last Year At HK$0.017

First half 2023 earnings released: EPS: HK$0.054 (vs HK$0.059 in 1H 2022)

UMP Healthcare Holdings Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 22% undervalued

UMP Healthcare Holdings Limited Announces Final Dividend for the Financial Year Ended 30 June 2022, Payable on 27 January 2023

Independent Non-Executive Director recently bought HK$80k worth of stock

UMP Healthcare Holdings Limited Announces Retirement of SUN Yiu Kwong as CEO, with Effect from 1 January 2023

Upcoming dividend of HK$0.03 per share

UMP Healthcare Holdings Limited Approves to Declare A Final Dividend for the Year Ended 30 June 2022

Chairman & CEO recently bought HK$111k worth of stock

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.03

Less than half of directors are independent

Chairman & CEO recently bought HK$101k worth of stock

UMP Healthcare Holdings Limited Proposes Final Dividend for the Year Ended 30 June 2022, Payable on 27 January 2023

UMP Healthcare Holdings (HKG:722) Will Pay A Larger Dividend Than Last Year At HK$0.03

UMP Healthcare Holdings Limited Proposes Final Dividend for the Year Ended 30 June 2022

Executive Director recently bought HK$72k worth of stock

UMP Healthcare Holdings (HKG:722) Is Increasing Its Dividend To HK$0.03

Third quarter 2022 earnings released: EPS: HK$0.017 (vs HK$0.002 in 3Q 2021)

UMP Healthcare Holdings Limited Proposes Final Dividend for the Year Ended 30 June 2022, Payable on 27 January 2023

UMP Healthcare Holdings Limited Provides Financial Guidance for Fiscal Year 2022

UMP Healthcare Holdings Limited to Report Fiscal Year 2022 Results on Sep 23, 2022

Chairman & CEO recently bought HK$158k worth of stock

Independent Non-Executive Director recently bought HK$155k worth of stock

Here's What To Make Of UMP Healthcare Holdings' (HKG:722) Decelerating Rates Of Return

Less than half of directors are independent

Independent Non-Executive Director recently bought HK$80k worth of stock

Upcoming dividend of HK$0.015 per share

First half 2022 earnings: Revenues and EPS in line with analyst expectations